FERRIPROX (ApoPharma USA, Inc.)


Welcome to the PulseAid listing for the FERRIPROX drug offered from ApoPharma USA, Inc.. This Iron Chelating Activity [MoA],Iron Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: ApoPharma USA, Inc.
NON-PROPRIETARY NAME: deferiprone
SUBSTANCE NAME: DEFERIPRONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Iron Chelating Activity [MoA],Iron Chelator [EPC]
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-09-09
END MARKETING DATE: 0000-00-00


FERRIPROX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFERRIPROX from ApoPharma USA, Inc.
LABELER NAME: ApoPharma USA, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2015-09-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52609-4502_e6340148-dcfd-2610-e320-389a6885f107
PRODUCT NDC: 52609-4502
APPLICATION NUMBER: NDA208030

Other DEFERIPRONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ApoPharma USA, Inc.FERRIPROX